Biological Psychiatry, ISSN 0006-3223, 2012, Volume 71, Issue 1, pp. 84 - 91
Background The hippocampus and its 5-hydroxytryptamine transmission plays an important role in depression related to its involvement in limbic circuit...
Psychiatry | neuronal plasticity | serotonin receptors | heteroreceptor | depression | Allosteric modulation | fibroblast growth factor receptor | PSYCHIATRY | ANTIDEPRESSANT TREATMENTS | VOLUME | MAJOR DEPRESSION | FLUOXETINE | NEUROSCIENCES | NEUROTROPHIC FACTORS | FACTOR SYSTEM | RAT-BRAIN | EXPRESSION | Immunoprecipitation | Humans | Fibroblast Growth Factor 2 - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Receptor, Serotonin, 5-HT1A - genetics | Neuronal Plasticity - drug effects | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Serotonin Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Neuronal Plasticity - physiology | Transfection | Neurons - physiology | Fluorescence Resonance Energy Transfer | Neurons - drug effects | Receptor, Serotonin, 5-HT1A - metabolism | Animals, Newborn | RNA, Small Interfering - pharmacology | Cells, Cultured | Computational Biology | Enzyme Inhibitors - pharmacology | Rats | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Hippocampus - cytology | Rats, Sprague-Dawley | Peptides - pharmacology | Animals | Signal Transduction - drug effects | Signal Transduction - physiology | Physiological aspects | Medical colleges | Neurosciences | Fibroblast growth factors | Depression, Mental
Psychiatry | neuronal plasticity | serotonin receptors | heteroreceptor | depression | Allosteric modulation | fibroblast growth factor receptor | PSYCHIATRY | ANTIDEPRESSANT TREATMENTS | VOLUME | MAJOR DEPRESSION | FLUOXETINE | NEUROSCIENCES | NEUROTROPHIC FACTORS | FACTOR SYSTEM | RAT-BRAIN | EXPRESSION | Immunoprecipitation | Humans | Fibroblast Growth Factor 2 - pharmacology | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Receptor, Serotonin, 5-HT1A - genetics | Neuronal Plasticity - drug effects | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Serotonin Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Neuronal Plasticity - physiology | Transfection | Neurons - physiology | Fluorescence Resonance Energy Transfer | Neurons - drug effects | Receptor, Serotonin, 5-HT1A - metabolism | Animals, Newborn | RNA, Small Interfering - pharmacology | Cells, Cultured | Computational Biology | Enzyme Inhibitors - pharmacology | Rats | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Hippocampus - cytology | Rats, Sprague-Dawley | Peptides - pharmacology | Animals | Signal Transduction - drug effects | Signal Transduction - physiology | Physiological aspects | Medical colleges | Neurosciences | Fibroblast growth factors | Depression, Mental
Journal Article
Molecules, ISSN 1420-3049, 2018, Volume 23, Issue 6, p. 1341
Due to the binding to a number of proteins to the receptor protomers in receptor heteromers in the brain, the term "heteroreceptor complexes" was introduced. A...
G protein-coupled receptors | Oligomerization | Galanin | Receptor tyrosine kinase | Depression | Heteroreceptor complexes | Fibroblast growth factor receptor | Receptor-receptor interactions | Serotonin 5-HT1A receptor | galanin | heteroreceptor complexes | BIOCHEMISTRY & MOLECULAR BIOLOGY | serotonin 5-HT1A receptor | DORSAL RAPHE | MAJOR DEPRESSION | ANTIDEPRESSANT DRUGS | CHEMISTRY, MULTIDISCIPLINARY | INTEGRATIVE MECHANISM | VENTRAL LIMBIC CORTEX | oligomerization | receptor-receptor interactions | fibroblast growth factor receptor | IN-VIVO | receptor tyrosine kinase | CENTRAL-NERVOUS-SYSTEM | DOPAMINE D1 RECEPTOR | depression | RAT-BRAIN | BINDING-SITES | Brain | Serotonin | Potassium channels (inwardly-rectifying) | Fluoxetine | Rats | Serotonin S2 receptors | Mental depression | Plasticity (hippocampal) | Serotonin S1 receptors | Proteins | Signaling | Receptors | Antidepressants | Fibroblast growth factor receptor 1 | Hippocampus | Neurologi | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Neurology | Medicinska och farmaceutiska grundvetenskaper | Neurovetenskaper
G protein-coupled receptors | Oligomerization | Galanin | Receptor tyrosine kinase | Depression | Heteroreceptor complexes | Fibroblast growth factor receptor | Receptor-receptor interactions | Serotonin 5-HT1A receptor | galanin | heteroreceptor complexes | BIOCHEMISTRY & MOLECULAR BIOLOGY | serotonin 5-HT1A receptor | DORSAL RAPHE | MAJOR DEPRESSION | ANTIDEPRESSANT DRUGS | CHEMISTRY, MULTIDISCIPLINARY | INTEGRATIVE MECHANISM | VENTRAL LIMBIC CORTEX | oligomerization | receptor-receptor interactions | fibroblast growth factor receptor | IN-VIVO | receptor tyrosine kinase | CENTRAL-NERVOUS-SYSTEM | DOPAMINE D1 RECEPTOR | depression | RAT-BRAIN | BINDING-SITES | Brain | Serotonin | Potassium channels (inwardly-rectifying) | Fluoxetine | Rats | Serotonin S2 receptors | Mental depression | Plasticity (hippocampal) | Serotonin S1 receptors | Proteins | Signaling | Receptors | Antidepressants | Fibroblast growth factor receptor 1 | Hippocampus | Neurologi | Basic Medicine | Neurosciences | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Neurology | Medicinska och farmaceutiska grundvetenskaper | Neurovetenskaper
Journal Article
Pharmacological Reports, ISSN 1734-1140, 10/2018, Volume 70, Issue 5, pp. 936 - 950
The existence of mGluR, NMDAR, AMPAR and putative KAR heteroreceptor complexes in synaptic and extrasynaptic regions of brain glutamate synapses represents a...
Basal ganglia | Oligomerization | Extrasynaptic | Ionotropic glutamate receptor | Heteroreceptor complexes | Allosteric receptor–receptor interactions | Metabotropic glutamate receptor | 3RD INTRACELLULAR LOOP | RECEPTOR-RECEPTOR INTERACTIONS | ENABLES CROSS-TALK | Allosteric receptor-receptor interactions | PROTEIN-COUPLED RECEPTORS | IMMUNOREACTIVE NEURONAL PROCESSES | ADENOSINE A(2A) RECEPTORS | RAT BASAL GANGLIA | HIGHER-ORDER OLIGOMERS | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | DOPAMINE D1 RECEPTOR
Basal ganglia | Oligomerization | Extrasynaptic | Ionotropic glutamate receptor | Heteroreceptor complexes | Allosteric receptor–receptor interactions | Metabotropic glutamate receptor | 3RD INTRACELLULAR LOOP | RECEPTOR-RECEPTOR INTERACTIONS | ENABLES CROSS-TALK | Allosteric receptor-receptor interactions | PROTEIN-COUPLED RECEPTORS | IMMUNOREACTIVE NEURONAL PROCESSES | ADENOSINE A(2A) RECEPTORS | RAT BASAL GANGLIA | HIGHER-ORDER OLIGOMERS | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | DOPAMINE D1 RECEPTOR
Journal Article
Expert Opinion on Therapeutic Targets, ISSN 1472-8222, 03/2015, Volume 19, Issue 3, pp. 377 - 398
Introduction: Several types of D2R and D1R heteroreceptor complexes were discovered in the indirect and direct pathways of the striatum, respectively. The...
allosteric receptor-receptor interactions | dopamine receptor agonists | Parkinson's disease | dopamine heteroreceptor complexes | dimerization | neurodegeneration | dyskinesias | G-protein-coupled receptors | motor complications | homodimerization | dopamine D2 receptor | l-DOPA | dopamine D1 receptor | Dyskinesias | Allosteric receptor-receptor interactions | Dopamine heteroreceptor complexes | Dopamine D2 receptor | Neurodegeneration | Homodimerization | L-DOPA | Dopamine receptor agonists | Dopamine D1 receptor | Dimerization | Motor complications | NMDA RECEPTOR | BASAL GANGLIA | D-ASPARTATE RECEPTORS | RAT MODEL | CENTRAL MONOAMINE NEURONS | LEVODOPA-INDUCED DYSKINESIA | ADENOSINE A(2A) RECEPTORS | PROTEIN-PROTEIN INTERACTIONS | PHARMACOLOGY & PHARMACY | MEDIUM SPINY NEURONS | ERGOT DRUGS | Dopamine Agonists - pharmacology | Levodopa - pharmacology | Antiparkinson Agents - pharmacology | Drug Partial Agonism | Receptors, Dopamine - metabolism | Humans | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Molecular Targeted Therapy | Parkinson Disease - physiopathology | Antiparkinson Agents - adverse effects | Animals | Dopamine Antagonists - pharmacology | Levodopa - adverse effects | Dopamine - metabolism
allosteric receptor-receptor interactions | dopamine receptor agonists | Parkinson's disease | dopamine heteroreceptor complexes | dimerization | neurodegeneration | dyskinesias | G-protein-coupled receptors | motor complications | homodimerization | dopamine D2 receptor | l-DOPA | dopamine D1 receptor | Dyskinesias | Allosteric receptor-receptor interactions | Dopamine heteroreceptor complexes | Dopamine D2 receptor | Neurodegeneration | Homodimerization | L-DOPA | Dopamine receptor agonists | Dopamine D1 receptor | Dimerization | Motor complications | NMDA RECEPTOR | BASAL GANGLIA | D-ASPARTATE RECEPTORS | RAT MODEL | CENTRAL MONOAMINE NEURONS | LEVODOPA-INDUCED DYSKINESIA | ADENOSINE A(2A) RECEPTORS | PROTEIN-PROTEIN INTERACTIONS | PHARMACOLOGY & PHARMACY | MEDIUM SPINY NEURONS | ERGOT DRUGS | Dopamine Agonists - pharmacology | Levodopa - pharmacology | Antiparkinson Agents - pharmacology | Drug Partial Agonism | Receptors, Dopamine - metabolism | Humans | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Molecular Targeted Therapy | Parkinson Disease - physiopathology | Antiparkinson Agents - adverse effects | Animals | Dopamine Antagonists - pharmacology | Levodopa - adverse effects | Dopamine - metabolism
Journal Article
Trends in Neurosciences, ISSN 0166-2236, 2015, Volume 39, Issue 1, pp. 5 - 15
The serotonin and neurotrophic factor hypotheses of depression are well known. The discovery of brain fibroblast growth factor receptor 1 (FGFR1)–5...
Neurology | allosteric receptor–receptor interactions | depression | fibroblast growth factor receptor 1 | heteroreceptor complexes | neural plasticity | 5-HT1A receptor | Neural plasticity | Allosteric receptor-receptor interactions | Depression | Heteroreceptor complexes | Fibroblast growth factor receptor 1 | ANTIDEPRESSANTS | PROTEIN | MESSENGER-RNA | RECEPTOR-RECEPTOR INTERACTIONS | GROWTH-FACTOR SYSTEM | NEURONS | RAT-BRAIN | DEEP BRAIN-STIMULATION | RAPHE | NEUROSCIENCES | FGFR1 | Animals | Depressive Disorder, Major - metabolism | Humans | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | Depressive Disorder, Major - drug therapy | Neurosciences - trends | Antidepressants | Depression, Mental | Fibroblast growth factors
Neurology | allosteric receptor–receptor interactions | depression | fibroblast growth factor receptor 1 | heteroreceptor complexes | neural plasticity | 5-HT1A receptor | Neural plasticity | Allosteric receptor-receptor interactions | Depression | Heteroreceptor complexes | Fibroblast growth factor receptor 1 | ANTIDEPRESSANTS | PROTEIN | MESSENGER-RNA | RECEPTOR-RECEPTOR INTERACTIONS | GROWTH-FACTOR SYSTEM | NEURONS | RAT-BRAIN | DEEP BRAIN-STIMULATION | RAPHE | NEUROSCIENCES | FGFR1 | Animals | Depressive Disorder, Major - metabolism | Humans | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | Depressive Disorder, Major - drug therapy | Neurosciences - trends | Antidepressants | Depression, Mental | Fibroblast growth factors
Journal Article
Trends in Pharmacological Sciences, ISSN 0165-6147, 12/2018, Volume 39, Issue 12, pp. 1008 - 1020
The concept of allosteric receptor–receptor interactions in G protein-coupled receptor homo- and heteroreceptor complexes in which they physically interact...
cocaine self-administration | receptor–receptor interactions | heteroreceptor complexes | long-term memory | addiction | D2 RECEPTORS | A(2A) RECEPTORS | RAT | RECEPTOR-RECEPTOR INTERACTIONS | PROTEIN EXPRESSION | DRUG-ADDICTION | DOPAMINE | TARGETS | PHARMACOLOGY & PHARMACY | SIGMA-1 RECEPTOR | NUCLEUS-ACCUMBENS | Cocaine - pharmacology | Animals | Cocaine-Related Disorders - metabolism | Humans | Nucleus Accumbens - metabolism | Cocaine-Related Disorders - physiopathology | Receptor, Adenosine A2A - metabolism | Reward | Nucleus Accumbens - drug effects | Receptors, Dopamine D2 - metabolism | Receptors, sigma - metabolism | Drug abuse | Cocaine
cocaine self-administration | receptor–receptor interactions | heteroreceptor complexes | long-term memory | addiction | D2 RECEPTORS | A(2A) RECEPTORS | RAT | RECEPTOR-RECEPTOR INTERACTIONS | PROTEIN EXPRESSION | DRUG-ADDICTION | DOPAMINE | TARGETS | PHARMACOLOGY & PHARMACY | SIGMA-1 RECEPTOR | NUCLEUS-ACCUMBENS | Cocaine - pharmacology | Animals | Cocaine-Related Disorders - metabolism | Humans | Nucleus Accumbens - metabolism | Cocaine-Related Disorders - physiopathology | Receptor, Adenosine A2A - metabolism | Reward | Nucleus Accumbens - drug effects | Receptors, Dopamine D2 - metabolism | Receptors, sigma - metabolism | Drug abuse | Cocaine
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 01/2015, Volume 456, Issue 1, pp. 489 - 493
The ascending midbrain 5-HT neurons known to contain 5-HT1A autoreceptors may be dysregulated in depression due to a reduced trophic support. With proximity...
Heteroreceptor complex | Fibroblast growth factor receptor 1 | Dimerization | Serotonin receptors | G-protein-coupled receptors | Receptor tyrosine kinases | DEPRESSION | BIOPHYSICS | TRANSACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | PROTEIN-COUPLED RECEPTORS | RAT-BRAIN | Peptides - chemistry | Humans | Fibroblast Growth Factor 2 - pharmacology | Gene Expression Regulation | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Rats | Male | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Rats, Sprague-Dawley | Animals | Serotonin - metabolism | HEK293 Cells | Fluorescence Resonance Energy Transfer | Protein Binding | Midbrain Raphe Nuclei - metabolism | Neurons - metabolism | Receptor, Serotonin, 5-HT1A - metabolism
Heteroreceptor complex | Fibroblast growth factor receptor 1 | Dimerization | Serotonin receptors | G-protein-coupled receptors | Receptor tyrosine kinases | DEPRESSION | BIOPHYSICS | TRANSACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | PROTEIN-COUPLED RECEPTORS | RAT-BRAIN | Peptides - chemistry | Humans | Fibroblast Growth Factor 2 - pharmacology | Gene Expression Regulation | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Rats | Male | 8-Hydroxy-2-(di-n-propylamino)tetralin - pharmacology | Rats, Sprague-Dawley | Animals | Serotonin - metabolism | HEK293 Cells | Fluorescence Resonance Energy Transfer | Protein Binding | Midbrain Raphe Nuclei - metabolism | Neurons - metabolism | Receptor, Serotonin, 5-HT1A - metabolism
Journal Article
Frontiers in Cellular Neuroscience, ISSN 1662-5102, 02/2017, Volume 11, p. 37
The introduction of allosteric receptor-receptor interactions in G protein-coupled receptor (GPCR) heteroreceptor complexes of the central nervous system (CNS)...
G protein-coupled receptor | Oligomerization | Addiction | Dopamine receptor | Serotonin receptor | Schizophrenia | Depression | Heteroreceptor complexes | heteroreceptor complexes | RECEPTOR-RECEPTOR INTERACTIONS | addiction | SEROTONIN RECEPTORS | PROTEIN-COUPLED RECEPTORS | schizophrenia | NEUROSCIENCES | dopamine receptor | DOPAMINE D2 RECEPTOR | serotonin receptor | VOLUME TRANSMISSION | oligomerization | ADENOSINE A(2A) RECEPTORS | HIGHER-ORDER OLIGOMERS | ANTIPSYCHOTIC-DRUGS | CENTRAL-NERVOUS-SYSTEM | depression | PARKINSONS-DISEASE | Brain | Neural networks | Depression, Mental | G proteins | Research | Health aspects | Fibroblast growth factor | Neurosciences | Transformation | Transcription factors | G protein-coupled receptors | Mental disorders | Galanin | Memory | Cognitive ability | Glutamic acid receptors | Mental depression | Drug development | Kinases | Neuromodulation | γ-Aminobutyric acid | Allosteric properties | Neostriatum | Reinforcement | Fibroblast growth factor receptor 1 | Dopamine D2 receptors | Communication | Adaptor proteins | Fibroblast growth factor 2 | Adenosine | Dopamine | Cortex | Pharmacology | Hypotheses | Psychopharmacology | Amphetamines | Cocaine | Adapter proteins | Binding sites | Hippocampus | Neurologi | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Neurology
G protein-coupled receptor | Oligomerization | Addiction | Dopamine receptor | Serotonin receptor | Schizophrenia | Depression | Heteroreceptor complexes | heteroreceptor complexes | RECEPTOR-RECEPTOR INTERACTIONS | addiction | SEROTONIN RECEPTORS | PROTEIN-COUPLED RECEPTORS | schizophrenia | NEUROSCIENCES | dopamine receptor | DOPAMINE D2 RECEPTOR | serotonin receptor | VOLUME TRANSMISSION | oligomerization | ADENOSINE A(2A) RECEPTORS | HIGHER-ORDER OLIGOMERS | ANTIPSYCHOTIC-DRUGS | CENTRAL-NERVOUS-SYSTEM | depression | PARKINSONS-DISEASE | Brain | Neural networks | Depression, Mental | G proteins | Research | Health aspects | Fibroblast growth factor | Neurosciences | Transformation | Transcription factors | G protein-coupled receptors | Mental disorders | Galanin | Memory | Cognitive ability | Glutamic acid receptors | Mental depression | Drug development | Kinases | Neuromodulation | γ-Aminobutyric acid | Allosteric properties | Neostriatum | Reinforcement | Fibroblast growth factor receptor 1 | Dopamine D2 receptors | Communication | Adaptor proteins | Fibroblast growth factor 2 | Adenosine | Dopamine | Cortex | Pharmacology | Hypotheses | Psychopharmacology | Amphetamines | Cocaine | Adapter proteins | Binding sites | Hippocampus | Neurologi | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Neurology
Journal Article
2013, Methods in Cell Biology, ISBN 9780124081437, Volume 117, 24
A large body of evidence indicates that G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) can form heteroreceptor complexes. In these...
BRET saturation assays | BRET competition assays | GPCR–RTK heteroreceptor complexes | Bioluminescence resonance energy transfer (BRET) | BRET kinetics and dose–response assays | Receptor–receptor interactions | Homodimerization | Heterodimerization | G protein-coupled receptors (GPCRs) | Heteroreceptor complexes | Allosteric modulation | Receptor tyrosine kinases (RTKs) | GPCR-RTK heteroreceptor complexes | BRET kinetics and dose-response assays | Receptor-receptor interactions | TRANSFER BRET | PLATFORMS | ASSAYS | OLIGOMERIZATION | LIVE CELLS | TECHNOLOGY | BRAIN | PLASTICITY | CELL BIOLOGY | Luciferases, Renilla - genetics | Fibroblast Growth Factor 2 - chemistry | Humans | Protein Multimerization | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Green Fluorescent Proteins - genetics | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Dose-Response Relationship, Drug | Bioluminescence Resonance Energy Transfer Techniques - methods | Adenosine A2 Receptor Agonists - pharmacology | Luciferases, Renilla - metabolism | HEK293 Cells | Fibroblast Growth Factor 2 - metabolism | Receptor, Adenosine A2A - genetics | Adenosine - chemistry | Adenosine A2 Receptor Agonists - chemistry | Binding, Competitive | Green Fluorescent Proteins - metabolism | Gene Expression | Phenethylamines - pharmacology | Signal Transduction | Phenethylamines - chemistry | Adenosine - pharmacology | Receptor, Adenosine A2A - metabolism | Protein Transport | Plasmids | Adenosine - analogs & derivatives | Protein Binding | Receptor, Adenosine A2A - chemistry | Receptor, Fibroblast Growth Factor, Type 1 - chemistry | Kinetics
BRET saturation assays | BRET competition assays | GPCR–RTK heteroreceptor complexes | Bioluminescence resonance energy transfer (BRET) | BRET kinetics and dose–response assays | Receptor–receptor interactions | Homodimerization | Heterodimerization | G protein-coupled receptors (GPCRs) | Heteroreceptor complexes | Allosteric modulation | Receptor tyrosine kinases (RTKs) | GPCR-RTK heteroreceptor complexes | BRET kinetics and dose-response assays | Receptor-receptor interactions | TRANSFER BRET | PLATFORMS | ASSAYS | OLIGOMERIZATION | LIVE CELLS | TECHNOLOGY | BRAIN | PLASTICITY | CELL BIOLOGY | Luciferases, Renilla - genetics | Fibroblast Growth Factor 2 - chemistry | Humans | Protein Multimerization | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Green Fluorescent Proteins - genetics | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Dose-Response Relationship, Drug | Bioluminescence Resonance Energy Transfer Techniques - methods | Adenosine A2 Receptor Agonists - pharmacology | Luciferases, Renilla - metabolism | HEK293 Cells | Fibroblast Growth Factor 2 - metabolism | Receptor, Adenosine A2A - genetics | Adenosine - chemistry | Adenosine A2 Receptor Agonists - chemistry | Binding, Competitive | Green Fluorescent Proteins - metabolism | Gene Expression | Phenethylamines - pharmacology | Signal Transduction | Phenethylamines - chemistry | Adenosine - pharmacology | Receptor, Adenosine A2A - metabolism | Protein Transport | Plasmids | Adenosine - analogs & derivatives | Protein Binding | Receptor, Adenosine A2A - chemistry | Receptor, Fibroblast Growth Factor, Type 1 - chemistry | Kinetics
Book Chapter
BBA - General Subjects, ISSN 0304-4165, 02/2017, Volume 1861, Issue 2, pp. 235 - 245
Recently, it was demonstrated that G-protein-coupled receptors (GPCRs) can transactivate tyrosine kinase receptors in absence of their ligands. In this work,...
Neural plasticity | Heteroreceptor complexes | M1 receptor | Transactivation | FGFR1 | receptor | PROGENITOR CELLS | ACTIVATED PROTEIN-KINASE | M-1 receptor | NEUROTROPHIC FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | C6 GLIOMA-CELLS | SUBVENTRICULAR ZONE | PRECURSOR CELL-PROLIFERATION | MESSENGER-RNAS | BIOPHYSICS | T-84 CELLS | RAT-BRAIN | EGF RECEPTOR | Neuronal Outgrowth - physiology | Oxotremorine - pharmacology | Rats, Wistar | Receptors, G-Protein-Coupled - metabolism | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Neuronal Plasticity - drug effects | Rats | Male | Receptors, Muscarinic - metabolism | Hippocampus - drug effects | Rats, Sprague-Dawley | Hippocampus - metabolism | Animals | Neuronal Plasticity - physiology | Signal Transduction - drug effects | Oxotremorine - analogs & derivatives | Receptors, Fibroblast Growth Factor - metabolism | Fibroblast Growth Factor 2 - metabolism | Signal Transduction - physiology | Neurons - metabolism | Neurons - drug effects | Receptor, Muscarinic M1 - metabolism | Fibroblast growth factors
Neural plasticity | Heteroreceptor complexes | M1 receptor | Transactivation | FGFR1 | receptor | PROGENITOR CELLS | ACTIVATED PROTEIN-KINASE | M-1 receptor | NEUROTROPHIC FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | C6 GLIOMA-CELLS | SUBVENTRICULAR ZONE | PRECURSOR CELL-PROLIFERATION | MESSENGER-RNAS | BIOPHYSICS | T-84 CELLS | RAT-BRAIN | EGF RECEPTOR | Neuronal Outgrowth - physiology | Oxotremorine - pharmacology | Rats, Wistar | Receptors, G-Protein-Coupled - metabolism | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Neuronal Plasticity - drug effects | Rats | Male | Receptors, Muscarinic - metabolism | Hippocampus - drug effects | Rats, Sprague-Dawley | Hippocampus - metabolism | Animals | Neuronal Plasticity - physiology | Signal Transduction - drug effects | Oxotremorine - analogs & derivatives | Receptors, Fibroblast Growth Factor - metabolism | Fibroblast Growth Factor 2 - metabolism | Signal Transduction - physiology | Neurons - metabolism | Neurons - drug effects | Receptor, Muscarinic M1 - metabolism | Fibroblast growth factors
Journal Article
MOLECULAR NEUROBIOLOGY, ISSN 0893-7648, 08/2017, Volume 54, Issue 6, pp. 4537 - 4550
Alzheimer's disease (AD) is a neurodegenerative disorder causing progressive memory loss and cognitive dysfunction. Anti-AD strategies targeting cell receptors...
Ionotropic receptors | Neuroprotection | Receptor heteromers | ACTIVATION | Parkinson's disease | BRAIN HISTAMINE | PROTEIN-COUPLED RECEPTORS | DISORDERS | Heteroreceptor complexes | NEUROSCIENCES | G-protein-coupled receptors | NMDA-RECEPTOR | HETEROMERS | Neurodegeneration | Transgenic animals | IN-VIVO | RAT HIPPOCAMPUS | Alzheimers disease | ANTAGONISTS | MODULATION | Dementia | Neurons - pathology | Phosphorylation | Signal Transduction | Humans | Protein Multimerization | Alzheimer Disease - therapy | Cerebral Cortex - pathology | Receptors, N-Methyl-D-Aspartate - metabolism | Male | Mice, Transgenic | Extracellular Signal-Regulated MAP Kinases - metabolism | Molecular Targeted Therapy | Rats, Sprague-Dawley | Alzheimer Disease - pathology | Receptors, Dopamine D1 - metabolism | Animals | Models, Biological | Cell Death | HEK293 Cells | Neurons - metabolism | Energy Transfer | Proto-Oncogene Proteins c-akt - metabolism | Receptors, Histamine H3 - metabolism
Ionotropic receptors | Neuroprotection | Receptor heteromers | ACTIVATION | Parkinson's disease | BRAIN HISTAMINE | PROTEIN-COUPLED RECEPTORS | DISORDERS | Heteroreceptor complexes | NEUROSCIENCES | G-protein-coupled receptors | NMDA-RECEPTOR | HETEROMERS | Neurodegeneration | Transgenic animals | IN-VIVO | RAT HIPPOCAMPUS | Alzheimers disease | ANTAGONISTS | MODULATION | Dementia | Neurons - pathology | Phosphorylation | Signal Transduction | Humans | Protein Multimerization | Alzheimer Disease - therapy | Cerebral Cortex - pathology | Receptors, N-Methyl-D-Aspartate - metabolism | Male | Mice, Transgenic | Extracellular Signal-Regulated MAP Kinases - metabolism | Molecular Targeted Therapy | Rats, Sprague-Dawley | Alzheimer Disease - pathology | Receptors, Dopamine D1 - metabolism | Animals | Models, Biological | Cell Death | HEK293 Cells | Neurons - metabolism | Energy Transfer | Proto-Oncogene Proteins c-akt - metabolism | Receptors, Histamine H3 - metabolism
Journal Article
Journal of Neural Transmission, ISSN 0300-9564, 4/2019, Volume 126, Issue 4, pp. 455 - 471
The adenosine homo, iso and heteroreceptor complexes in the basal ganglia play a highly significant role in modulating the indirect and direct pathways and the...
G protein-coupled receptor | Neurology | Neurosciences | Basal ganglia | Oligomerization | Medicine & Public Health | Neurodegeneration | Parkinson’s diseases | Adenosine receptor | Heteroreceptor complexes | Psychiatry | Neurology and Preclinical Neurological Studies - Original
G protein-coupled receptor | Neurology | Neurosciences | Basal ganglia | Oligomerization | Medicine & Public Health | Neurodegeneration | Parkinson’s diseases | Adenosine receptor | Heteroreceptor complexes | Psychiatry | Neurology and Preclinical Neurological Studies - Original
Journal Article